The provision of Abbott FreeStyle Libre Flash Glucose Monitoring System is not routinely funded by the CCG and is subject to this restricted policy.
On 7 March 2019 NHS England announced the national arrangements for funding and criteria for the use of Freestyle Libre® Flash GlucoseMonitoring in Type 1 diabetes
Bristol, North Somerset and South Gloucestershire CCG continues to
work closely with local hospital and community diabetes teams to support the
introduction and prescribing of Freestyle Libre® in line with national
arrangements and have developed our Criteria Based Access policy to support